Correlation Between Hisamitsu Pharmaceutical and HANSOH PHARMAC

Can any of the company-specific risk be diversified away by investing in both Hisamitsu Pharmaceutical and HANSOH PHARMAC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hisamitsu Pharmaceutical and HANSOH PHARMAC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hisamitsu Pharmaceutical Co and HANSOH PHARMAC HD 00001, you can compare the effects of market volatilities on Hisamitsu Pharmaceutical and HANSOH PHARMAC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hisamitsu Pharmaceutical with a short position of HANSOH PHARMAC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hisamitsu Pharmaceutical and HANSOH PHARMAC.

Diversification Opportunities for Hisamitsu Pharmaceutical and HANSOH PHARMAC

0.2

Correlation Coefficient

Hisamitsu Pharmaceutical  HANSOH PHARMAC

Modest diversification

The 3 months correlation between Hisamitsu and HANSOH is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Hisamitsu Pharmaceutical Co and HANSOH PHARMAC HD 00001 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HANSOH PHARMAC HD and Hisamitsu Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hisamitsu Pharmaceutical Co are associated (or correlated) with HANSOH PHARMAC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HANSOH PHARMAC HD has no effect on the direction of Hisamitsu Pharmaceutical i.e., Hisamitsu Pharmaceutical and HANSOH PHARMAC go up and down completely randomly.

Pair Corralation between Hisamitsu Pharmaceutical and HANSOH PHARMAC

Assuming the 90 days horizon Hisamitsu Pharmaceutical Co is expected to generate 0.39 times more return on investment than HANSOH PHARMAC. However, Hisamitsu Pharmaceutical Co is 2.6 times less risky than HANSOH PHARMAC. It trades about 0.08 of its potential returns per unit of risk. HANSOH PHARMAC HD 00001 is currently generating about -0.08 per unit of risk. If you would invest  2,440  in Hisamitsu Pharmaceutical Co on October 12, 2024 and sell it today you would earn a total of  140.00  from holding Hisamitsu Pharmaceutical Co or generate 5.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Hisamitsu Pharmaceutical Co  vs.  HANSOH PHARMAC HD 00001

Hisamitsu Pharmaceutical

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Hisamitsu Pharmaceutical Co are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Hisamitsu Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in February 2025.

HANSOH PHARMAC HD

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HANSOH PHARMAC HD 00001 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Hisamitsu Pharmaceutical and HANSOH PHARMAC

The main advantage of trading using opposite Hisamitsu Pharmaceutical and HANSOH PHARMAC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hisamitsu Pharmaceutical position performs unexpectedly, HANSOH PHARMAC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HANSOH PHARMAC will offset losses from the drop in HANSOH PHARMAC's long position.

The idea behind Hisamitsu Pharmaceutical Co and HANSOH PHARMAC HD 00001 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.